Details

<p>Contributors ix</p> <p>Foreword xv</p> <p>Preface xvii</p> <p>Acknowledgments xix</p> <p>1 West Africa 2013: Re-examining Ebola 1<br /><i>Daniel G. Bausch and Amanda Rojek</i></p> <p>2 Preparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught Us 39<br /><i>Jay B. Varkey and Bruce S. Ribner</i></p> <p>3 Ebola Virus Disease: Therapeutic and Potential Preventative Opportunities 53<br /><i>Robert Fisher and Luciana Borio</i></p> <p>4 Middle East Respiratory Syndrome (MERS) 73<br /><i>Sonja A. Rasmussen, Amelia K. Watson, and David L. Swerdlow</i></p> <p>5 The Emergence of Enterovirus D-68 105<br /><i>Kevin Messacar, Mark J. Abzug, and Samuel R. Dominguez</i></p> <p>6 The Role of Punctuated Evolution in the Pathogenicity of Influenza Viruses 121<br /><i>Jonathan A. McCullers</i></p> <p>7 Measles in the United States since the Millennium: Perils and Progress in the Postelimination Era 131<br /><i>Anne Schuchat, Amy Parker Fiebelkorn, and William Bellini</i></p> <p>8 Chikungunya Virus: Current Perspectives on a Reemerging Virus 143<br /><i>Clayton R. Morrison, Kenneth S. Plante, and Mark T. Heise</i></p> <p>9 Zika Virus Disease 163<br /><i>Werner Slenczka</i></p> <p>10 West Nile Virus Infection 175<br /><i>James J. Sejvar</i></p> <p>11 Mobilization of Carbapenemase-Mediated Resistance in Enterobacteriaceae 201<br /><i>Amy Mathers</i></p> <p>12 Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century 213<br /><i>Magnus Unemo, Carlos del Rio, and William M. Shafer</i></p> <p>13 Bordetella holmesii: Still Emerging and Elusive 20 Years On 239<br /><i>Laure F. Pittet and Klara M. Posfay-Barbe</i></p> <p>14 Cronobacter spp. 255<br /><i>Brian P. Blackwood and Catherine J. Hunter</i></p> <p>15 Clostridium difficile Infection 265<br /><i>Jae Hyun Shin, Esteban Chaves-Olarte, and Cirle A. Warren</i></p> <p>16 Emerging Tick-Borne Bacterial Pathogens 295<br /><i>Tahar Kernif, Hamza Leulmi, Didier Raoult, and Philippe Parola</i></p> <p>17 Bordetella pertussis 311<br /><i>Delma J. Nieves and Ulrich Heininger</i></p> <p>18 Invasive Infections with Nontyphoidal Salmonella in Sub-Saharan Africa 341<br /><i>Barbara E. Mahon and Patricia I. Fields</i></p> <p>19 Fungal Infections Associated with Contaminated Steroid Injections 359<br /><i>Carol A. Kauffman and Anurag N. Malani</i></p> <p>20 Emerging Fungal Infections in the Pacific Northwest: The Unrecognized Burden and Geographic Range of Cryptococcus gattii and Coccidioides immitis 375<br /><i>Shawn R. Lockhart, Orion Z. McCotter, and Tom M. Chiller</i></p> <p>21 The Emerging Amphibian Fungal Disease, Chytridiomycosis: A Key Example of the Global Phenomenon of Wildlife Emerging Infectious Diseases 385<br /><i>Jonathan E. Kolby and Peter Daszak</i></p> <p>22 Artemisinin-Resistant Plasmodium falciparum Malaria 409<br /><i>Rick M. Fairhurst and Arjen M. Dondorp</i></p> <p>Index 431</p>

</span></p> <p class=MsoNormal><span lang=EN-CA>Description</span> <p class=MsoNormal><span lang=EN-CA>The 10th volume of this series, which originated in 1998, remains highly pertinent and informative as emerging and re-emerging infectious diseases become ever more important. Written by 49 well-qualified authors (including over a dozen from outside the U.S.) from major academic institutions as well as the CDC, FDA, NIH, and WHO, the 22 chapters examine emerging pathogens MERS, Enterovirus D68, Chikungunya, Zika, carbapenem-resistant Enterobacteriaceae (CRE), antibiotic-resistant gonorrhea, etc. Three chapters are dedicated to Ebola due to its recent impact and general interest.</span> <p class=MsoNormal><span lang=EN-CA>Purpose</span> <p class=MsoNormal><span lang=EN-CA>The three well-known editors seek to update readers on a wide-ranging list of prominent emerging viral, bacterial, and fungal pathogens as well as a few less well-known or more esoteric pathogens such as B. holmesii, Cronobacter spp., tick-borne bacterial pathogens, and amphibian fungal diseases. In addition, several chapters deal with more mechanistic concerns such as punctuated evolution in the pathogenicity of influenza, fungal contamination of steroid injections, and challenges in preventing the re-emergence of measles.</span> <p class=MsoNormal><span lang=EN-CA>Audience</span> <p class=MsoNormal><span lang=EN-CA>Students, teachers, clinicians, laboratorians, and investigators in the disciplines of microbiology, infectious diseases, and public health will find value in the concise, well-written, and adequately referenced chapters.</span> <p class=MsoNormal><span lang=EN-CA>Features</span> <p class=MsoNormal><span lang=EN-CA>The foreword and preface do a nice job of setting the scene. The first three chapters on Ebola are organized into West African experience, lessons from Ebola in preparing for serious communicable diseases in the United States, and Ebola therapeutics. Although each chapter is excellent on its own, there is substantial redundancy when read together. To better hold the reader's attention, the authors of almost all of the chapters (exceptions are non-typhoidal salmonella and Zika) offer appropriate graphics, charts, and tables. The chapters on MERS, measles, Enterovirus D68, and C. difficile are concise yet comprehensive reviews. The scope of the chapter on CRE concentrates on epidemiology and laboratory detection but does not address other clinical issues.</span> <p class=MsoNormal><span lang=EN-CA>Assessment</span> <p class=MsoNormal><span lang=EN-CA>Global forces such as population growth, climate change, world travel, and trade will continue to influence the emergence and transmission of infectious diseases. This volume nicely summarizes information on a variety of pathogens and serves as a great reminder of the importance of preparedness and public health on a national and global scale.</span> <p class=MsoNormal><span lang=EN-CA>Weighted Numerical Score: 90 - 4 Stars!</span> <p class=MsoNormal><b><span lang=EN-CA>-DOODY&apos;S REVIEW SERVICE (NO INDIVIDUAL REVIEWER NOTED)<o:p></o:p></span></b> <p class=MsoNormal><span lang=EN-CA>

<p><b>Emerging Infections 10</b> <p>First Edition <p><i>Essential resource for the fight against emerging infectious diseases</i> <p>Incidences such as the 2014 Ebola epidemic in West Africa and the 2015 appearance of Zika in Brazil provide dramatic evidence of the continued ability of microbes to emerge, spread, adapt, and threaten global health. The challenge facing infectious disease specialists and public health professionals is to improve and find new diagnostic, therapeutic, and prevention strategies. <p>The editors of the 10th installment of the Emerging Infections series have compiled the perspectives of leading infectious disease experts into 22 chapters that provide important updates on a broad range of emerging and reemerging bacterial, viral, parasitic, and fungal infectious diseases in the United States and globally. In addition to focusing on MERS, Ebola virus disease, chikungunya, and Zika virus disease, <i>Emerging Infections 10</i> explores the global threat of antimicrobial resistance in reviews on carbapenem-resistant Enterobacteriaceae, multiply-resistant gonococcal infections, non-typhoidal Salmonella infections, and artemisinin-resistant Plasmodium falciparum malaria. Topics include both recently- and long-recognized diseases that pose challenges for the clinical, laboratory, research, public health, and animal health communities. <p><i>Emerging Infections 10</i> presents new and emerging strategies to prevent, control, and eradicate infectious diseases and guides readers to the primary literature where they can explore individual topics in greater depth. This book is a valuable reference for professionals in microbiology, epidemiology, public health, and clinical and veterinary medicine.

US